Laboratory Corporation of America has agreed to pay the United States $2.1M to resolve allegations that it violated the federal False Claims Act by overbilling the Department of Defense for genetic tests performed by GeneDx, a third-party reference laboratory used by Labcorp to perform genetic tests for military members. The civil settlement resolves a lawsuit filed by Donna Hecker-Gross, a former employee of Labcorp, under the whistleblower provision of the False Claims Act, the Justice Department said in a statement. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LH:
- Enzo Surges after Divestiture of Clinical Labs Division
- Enzo Biochem to sell Clinical Laboratory division to Labcorp, terms undisclosed
- Labcorp price target lowered to $288 from $304 at Credit Suisse
- Labcorp price target lowered to $290 from $315 at Wells Fargo
- Labcorp price target raised to $300 from $285 at Baird